The induction of macrophage gene expression by LPS predominantly utilizes Myd88-independent signaling cascades

Physiological Genomics

Volumn 19, Issue , 2005, Pages 319-330

  Björkbacka, Harry ^a,d   Fitzgerald, Katherine A ^b   Huet, François ^a,d   Li, Xiaoman ^c   Gregory, James A ^a   Lee, Melinda A ^a   Ordija, Christine M ^a   Dowley, Nicole E ^b   Golenbock, Douglas T ^b   Freeman, Mason W ^a,d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD UNIVERSITY   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Cellular activation; Gene regulation; Lipopolysaccharide; Monocytes macrophages; Signal transduction

Indexed keywords

LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88;

ARTICLE; DNA MICROARRAY; ESCHERICHIA COLI; GENE EXPRESSION; GENETIC TRANSCRIPTION; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; CELLS, CULTURED; DNA-BINDING PROTEINS; ESCHERICHIA COLI K12; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTOR-3; KIDNEY; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; MYELOID DIFFERENTIATION FACTOR 88; NF-KAPPA B; PROTEINS; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TRANSCRIPTION FACTORS; TRANSFECTION;

ESCHERICHIA COLI;

EID: 19944362471     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00128.2004     Document Type: Article

References (56)

1. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, Sakagami M, Nakanishi K, and Akira S. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150, 1998.
2. Bin LH, Xu LG, and Shu HB. TIRP, a novel Toll/interleukin-1 receptor (TIR) domain-containing adapter protein involved in TIR signaling. J Biol Chem 278: 24526-24532, 2003.
3. Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, and Relman DA. Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci USA 99: 972-977, 2002.
4. Doyle S, Vaidya S, O'Connell R, Dadgostar H, Dempsey P, Wu T, Rao G, Sun R, Haberland M, Modlin R, and Cheng G. IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17: 251-263, 2002.
5. Dunne A and O'Neill LA. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003 Feb 25 (171): re3.
6. Edelson BT and Unanue ER. MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria: no role for either in macrophage listericidal activity. J Immunol 169: 3869-3875, 2002.
7. Eichler GS, Huang S, and Ingber DE. Gene Expression Dynamics Inspector (GEDI): for integrative analysis of expression profiles. Bioinformatics 19: 2321-2322, 2003.
8. 7a.Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, and Golenbock DT. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J Exp Med 198: 1043-1055, 2003.
9. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, and Maniatis T. IKKε and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4: 491-496, 2003.
10. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, and O'Neill LA. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 413: 78-83, 2001.
11. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, and Golenbock DT. LPS-TLR4 signaling to IRF-3/7 and NF-κB involves the toll adapters TRAM and TRIF. J Exp Med 198: 1043-1055, 2003.
12. Fukao T and Koyasu S. PI3K and negative regulation of TLR signaling. Trends Immunol 24: 358-363, 2003.
13. Hattori Y, Akimoto K, Matsumura M, Tseng CC, Kasai K, and Shimoda S. Effect of cycloheximide on the expression of LPS-inducible iNOS, IFN-beta, and IRF-1 genes in J774 macrophages. Biochem Mol Biol Int 40: 889-896, 1996.
14. Hirohashi N and Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun 64: 1011-1015, 1996.
15. Hirschfeld M, Ma Y, Weis JH, Vogel SN, and Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165: 618-622, 2000.
16. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, Goode J, Lin P, Mann N, Mudd S, Crozat K, Sovath S, Han J, and Beutler B. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424: 743-748. 2003.
17. Horng T, Barton GM, and Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2: 835-841, 2001.
18. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, Young RA, Lander ES, and Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870-875, 2001.
19. Janeway CA Jr and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20: 197-216, 2002.
20. Janssens S and Beyaert R. A universal role for MyD88 in TLR/IL-1R-mediated signaling. Trends Biochem Sci 27: 474-482, 2002.
21. Janssens S, Burns K, Tschopp J, and Beyaert R. Regulation of interleukin-1- and lipopolysaccharide-induced NF-kappaB activation by alternative splicing of MyD88. Curr Biol 12: 467-471, 2002.
22. Jiang Z, Mak TW, Sen G, and Li X. Toll-like receptor 3-mediated activation of NF-κB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-β. Proc Natl Acad Sci USA 101: 3533-3538, 2004.
23. Kaisho T, Takeuchi O, Kawai T, Hoshino K, and Akira S. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J Immunol 166: 5688-5694, 2001.
24. Kawai T, Adachi O, Ogawa T, Takeda K, and Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122, 1999.
25. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, and Akira S. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894, 2001.
26. Kobayashi K, Hernandez LD, Galan JE, Janeway CA Jr, Medzhitov R, and Flavell RA. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110: 191-202, 2002.
27. McCarthy JE. Posttranscriptional control of gene expression in yeast. Microbiol Mol Biol Rev 62: 1492-1553, 1998.
28. Mitcham JL, Parnet P, Bonnert TP, Garka KE, Gerhart MJ, Slack JL, Gayle MA, Dower SK, and Sims JE. T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J Biol Chem 271: 5777-5783, 1996.
29. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, Seki E, Sato S, Takeuchi O, Takeda K, Akira S, Yamanishi K, Kawase I, Nakanishi K, and Kishimoto T. SOCS-1 participates in negative regulation of LPS responses. Immunity 17: 677-687, 2002.
30. Nau GJ, Richmond JF, Schlesinger A, Jennings EG, Lander ES, and Young RA. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99: 1503-1508, 2002.
31. Nau GJ, Schlesinger A, Richmond JF, and Young RA. Cumulative toll-like receptor activation in human macrophages treated with whole bacteria. J Immunol 170: 5203-5209, 2003.
32. O'Neill LA, Fitzgerald KA, and Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 24: 286-290, 2003.
33. O'Neill LA, Fitzgerald KA, and Bowie AG. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol 24: 286-289, 2003.
34. Oshiumi H, Matsumoto M, Funami K, Akazawa T, and Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat Immunol 4: 161-167, 2003.
35. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, and Seya T. TIR-containing adapter molecule (TICACM-2): a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 278: 49751-49762, 2003.
36. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, and Vogel SN. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166: 574-581, 2001.
37. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, and Peterson C. BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data. Genome Biol 3: SOFTWARE0003, 2002.
38. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, and Akira S. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J Immunol 171: 4304-4310, 2003.
39. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, Adachi K, Futatsugi S, Kuida K, Takeuchi O, Okamura H, Fujimoto J, Akira S, and Nakanishi K. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J Immunol 166: 2651-2657, 2001.
40. Shaffer AL, Rosenwald A, Hurt EM, Giltnane JM, Lam LT, Pickeral OK, and Staudt LM. Signatures of the immune response. Immunity 15: 375-385, 2001.
41. Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, and Jongeneel CV. Kappa B-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor alpha gene in primary macrophages. J Exp Med 171: 35-47, 1990.
42. Skerrett SJ, Liggitt HD, Hajjar AM, and Wilson CB. Cutting edge: myeloid differentiation factor 88 is essential for pulmonary host defense against Pseudomonas aeruginosa but not Staphylococcus aureus. J Immunol 172: 3377-3381, 2004.
43. Swantek JL, Cobb MH, and Geppert TD. Jun N-terminal kinase/stress- activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK. Mol Cell Biol 17: 6274-6282, 1997.
44. Sweet MJ, Campbell CC, Sester DP, Xu D, McDonald RC, Stacey KJ, Hume DA, and Liew FY. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J Immunol 168: 392-399, 2002.
45. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, Trajkovic V, Campbell CC, Xu D, and Liew FY. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J Immunol 166: 6633-6639, 2001.
46. Takaoka A and Taniguchi T. New aspects of IFN-alpha/beta signalling in immunity, oncogenesis and bone metabolism. Cancer Sci 94: 405-411, 2003.
47. Takeuchi O, Hoshino K, and Akira S. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165: 5392-5396, 2000.
48. Vogel SN, Fitzgerald KA, and Fenton MJ. TLRs: differential adapter utilization by Toll-like receptors mediates TLR-specific patterns of gene expression. Mol Intervent 3: 466-477, 2003.
49. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, and Li X. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol 4: 920-927, 2003.
50. Wang X and Seed B. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31: e154, 2003.
51. Weighardt H, Jusek G, Mages J, Lang R, Hoebe K, Beutler B, and Holzmann B. Identification of a TLR4- and TRIF-dependent activation program of dendritic cells. Eur J Immunol 34: 558-564, 2004.
52. Weighardt H, Kaiser-Moore S, Vabulas RM, Kirschning CJ, Wagner H, and Holzmann B. Cutting edge: myeloid differentiation factor 88 deficiency improves resistance against sepsis caused by polymicrobial infection. J Immunol 169: 2823-2827, 2002.
53. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, and Akira S. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640-643, 2003.
54. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, Takeuchi O, Takeda K, and Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 4: 1144-1150, 2003.
55. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, and Akira S. Cutting Edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 169: 6668-6672, 2002.
56. Zhang H, Ramanathan Y, Soteropoulos P, Recce ML, and Tolias PP. EZ-Retrieve: a web-server for batch retrieval of coordinate-specified human DNA sequences and underscoring putative transcription factor-binding sites. Nucleic Acids Res 30: e121, 2002.